About ALIVE
ALIVE is a venture capital firm founded in 2020. It is primarily based out of Tel Aviv, Israel. As of Sep 2026, ALIVE is an active investor, having invested in 16 companies, with 1 new investment in the last 12 months. It primarily invests in Series B round in Israel based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Series B round of UltraSight Overall, ALIVE portfolio has seen 3 acquisitions, namely Wisdo, Cynerio and Innovalve. A lot of funds co-invest with ALIVE, with names like Leumi Partners sharing a substantial percentage of its portfolio. ALIVE has team of 8 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 2 more
Deals in last 12 months
ALIVE's List of Top Investments
ALIVE has a portfolio of 16 companies. Their most notable investments are in Vessi Medical and ONCOHOST.Their portfolio spans across Israel, United States and Australia. They have invested in HealthTech, Life Sciences, Enterprise Applications and 7 other sectors, across stages such as Series A, Series B and 2 more. Here is the list of top investments by ALIVE:1. Wisdo
Online community platform for multiple health conditions. The platform enables users to connect, share and learn about health-related conditions and receive tips and guidance. It offers a community platform for anxiety, self-care, depression, relationship advice, cancer, diabetes, and more.
Key facts about Wisdo
- Founded Year: 2015
- Location: Ramat Hasharon (Israel)
- Stage: Acquired
- Total Funding till date: $11M
- Employee Count: 36 as on Aug 31, 2026
- Investors: For Good Ventures, RONA Holdings and 12 Others
- Latest Funding Round: Series A, Jan 06, 2023, $*****
- Highlight: Acquired
2. Medisafe
Provider of digital medication engagement and adherence platform. The system delivers omnichannel support including reminders, drug‑interaction alerts, refill tracking, caregiver sharing, and health measurement logs. It integrates SMS, web, mobile apps, wearables, and voice agents to guide patients through their treatment journey. Designed for pharmaceutical brands, providers, and patients, the platform combines AI‑enabled interventions with analytics and SDK tools for custom branded digital companions and care coordination.
Key facts about Medisafe
- Founded Year: 2012
- Location: Boston (United States)
- Stage: Series C
- Total Funding till date: $51.5M
- Employee Count: 99 as on Aug 31, 2026
- Investors: EG Capital Advisors, Qualcomm Ventures and 19 Others
- Latest Funding Round: Series C, Feb 25, 2021, $*****
- Highlight: Editors' Pick
3. UltraSight
AI-based platform providing ultrasound diagnosis for cardiac disorders. The platform provides solutions for clinical decision support through cardiac imaging and sonography. The software can be paired with ultrasound devices for sonography analysis and diagnosis.
Key facts about UltraSight
- Founded Year: 2018
- Location: Rehovot (Israel)
- Stage: Series B
- Total Funding till date: $38.1M
- Employee Count: 42 as on Aug 31, 2026
- Investors: Philips HealthWorks, New York University and 12 Others
- Latest Funding Round: Series B, Sep 23, 2026, $*****
4. Scout
Online platform for investments in eco-friendly brands, women-led companies, and bitcoin. Offers curated themes as per the user's interests. Provides personalized portfolio as per the investment goals and is monitored by investment professionals. Users can receive insights on portfolio performance.
Key facts about Scout
- Founded Year: 2021
- Location: New York City (United States)
- Stage: Series A
- Total Funding till date: $3.74M
- Employee Count: 31 as on Mar 31, 2026
- Investors: Broadhaven Ventures, Hustle Fund and 17 Others
- Latest Funding Round: Angel, Feb 06, 2025, $*****
- Highlight: Editors' Pick
_1579513303815.png?format=webp&height=120&width=120){kind=logo}
5. Cynerio
Cynerio provides solutions for health data security. The network-based platform gives data visibility into the function and behavior of every medical device, provides protection to ensure operational availability and patient safety. It continuously discovers and classifies all the connected medical devices maps their network behavior based on the context of their communications. It also detects threats in the healthcare context behavior analysis.
Key facts about Cynerio
ALIVE's Year-on-Year Investment Trends
ALIVE has invested in 16 companies over the last 6 years, with an average of 3 new investments annually in the last 5 years. In 2025, it made 1 investment, while as of Sep 2026, it has made 1 investment in this year. Its most recent first time investment was in UltraSight and most recent follow-on round was in Navina.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 0 | 1 | 1 |
2024 | 1 | 1 | 2 |
2023 | 5 | 0 | 5 |
2022 | 5 | 0 | 5 |
2021 | 3 | 0 | 3 |
2020 | 1 | 0 | 1 |
ALIVE's Investments by Stage
ALIVE has made 5 investments in Series A stage with an average round size of $9.57M, 5 investments in Series B stage with an average round size of $22.5M, 3 investments in Seed stage with an average round size of $4.9M and 3 investments in Series C stage with an average round size of $40M.Stage of entry | No. of Investments |
|---|---|
Series A | 5 |
Series B | 5 |
Seed | 3 |
Series C | 3 |
Note: We have considered here, only first round of investments
ALIVE's Investments by Sector
ALIVE has a diverse portfolio, with companies operating in the HealthTech, Life Sciences, Artificial Intelligence - Industry Applications, Enterprise Applications and Consumer. Notably, it has invested in 16 Tech companies, 12 Enterprise (B2B) companies, 5 Consumer (B2C) companies and at least 4 companies focusing on Software.Sector | No. of Investments |
|---|---|
HealthTech | 8 |
Life Sciences | 7 |
Artificial Intelligence - Industry Applications | 3 |
Enterprise Applications | 3 |
Consumer | 2 |
Others | 11 |
Note: We have considered here, only first round of investments
ALIVE's Investments by Geography
ALIVE has made most investments in Israel (10), followed by United States where it has made 5 investments.Country | No. of Investments |
|---|---|
Israel | 10 |
United States | 5 |
Australia | 1 |
Note: We have considered here, only first round of investments
ALIVE's recent investments
ALIVE has made 1 investments in 2026 so far - UltraSight.Here are the most recent investments by ALIVE:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 23, 2026 | Israel | Series B | 9009 | [+6] | |
Mar 25, 2025 | Israel | Series C | 9674 | [+2] | |
Jul 23, 2024 | Israel | Series D | 3559 | [+5] | |
Feb 14, 2024 | Israel | Series A | 2428 | ||
Aug 29, 2023 | Israel | Seed | 2942 | [+2] |
Acquired companies in ALIVE's Portfolio
3 companies from ALIVE's portfolio have been acquired. The most recent acquisition was Wisdo in Oct 2025 by Talkspace for $*****.Here are ALIVE's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 06, 2025 | Jan 06, 2023 | Series A | 6811 | |
Jul 26, 2025 | May 18, 2021 | Series B | 3692 | |
Jul 15, 2024 | Aug 23, 2020 | Series B | 5635 |
_1579513303815.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of ALIVE
ALIVE has a team of 8 members including 3 Partners, 1 Venture Partner and 2 Principals located in Israel. ALIVE's team does not sit on the board of any company as of now.Here is a list of all team members in ALIVE:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | Israel | - | ||
Partner | Tel Aviv | - | ||
Venture Partner | - | - | - | |
Principal | - | - | ||
Principal | Israel | - |
Co-investors of ALIVE
Over the past 6 years, 125 investors have co-invested in ALIVE's portfolio companies. This includes funds and angels.
- Invested before ALIVE: Pitango, Octopus Ventures and 34 others have invested in rounds before ALIVE. There are 2 companies where Pitango has invested before ALIVE and 1 company where Octopus Ventures has invested before ALIVE.
- Top Co-investors of ALIVE: 78 investors entered a company along with ALIVE. These include investors like Leumi Partners (2 companies).
- Invested after ALIVE: A total of 11 investors have invested in ALIVE's portfolio after their investments. Top Investors include Techstars (1 company), Gener8tor (1 company) and Andy Katz (1 company).
Recent News related to ALIVE
•
UltraSight Secures $24M Series B2 Funding to Expand AI-Powered Cardiac UltrasoundHIT Consultant•Sep 23, 2026•Mayo Clinic, Star51 Capital, Connecticut Innovations, UltraSight and 1 other
•
Clinical AI Leader Navina Secures $55M Series C Funding Led by Growth Equity at Goldman SachsPR Newswire•Mar 25, 2025•Navina, Goldman Sachs, Vertex Ventures Israel, Grove Ventures and 3 others
•
Navina secures $55M Series C led by Goldman Sachs to expand AI-driven healthcare inteCTech•Mar 25, 2025•Navina, Goldman Sachs, Vertex Ventures Israel, Grove Ventures and 1 other
•
•
Vessi Medial raises $16.5M for cryotherapy for bladder cancerMassDevice•Feb 14, 2024•Vessi Medical, ALIVE, Agriline Products, The Trendlines Group and 1 other
•
Nevia Bio Closes $3M Seed Funding RoundFinSMEs•Aug 30, 2023•Nevia Bio, MindUp, Pitango, ALIVE and 2 others
•
Append Medical Raises $4.35M in Initial Closing of Extended Series AFinSMEs•Jul 06, 2023•Append Medical, Shoni Health Ventures, ALIVE
•
Magenta Medical Closes $55 Million Funding RoundMedical Product Outsourcing•Jul 03, 2023•Magenta Medical, Orbimed, Pitango, ALIVE
•
Outliers dba Thesis has filed a notice of an exempt offering of securities to raise $15,391,167.00 in New Equity Investmentintelligence360•May 05, 2023•Thesis, Unilever Ventures, REDO Ventures, ALIVE and 1 other
•
Thesis Raises Another $8.4M to Improve your Cognitive Performance Based on Your Body’s Brain ChemistryAlleyWatch•May 04, 2023•Thesis, Unilever Ventures, REDO Ventures, ALIVE and 1 other
